Pharma Reviews: Pharma is far from feeling healthy, GST adds to pain

While the former is preferred for its minimum exposure to the Indian market and GST rollout, absence of USFDA woes and attractive valuations, the ...
Read more: Pharma is far from feeling healthy, GST adds to pain